Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Deutschbein

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German SurveyUlf Elbelt, Sven M Schlaffer, Michael Buchfelder, et al.
European Journal of Endocrinology|December 26, 2023
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgeryKristina Isand, Richard Feelders, Thierry Brue, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
European Urology|November 26, 2013
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancerAlfredo Berruti, Martin Fassnacht, Harm Haak, et al.
European Journal of Endocrinology|October 7, 2017
Somatic <i>USP8</i> mutations are frequent events in corticotroph tumor progression causing Nelson's tumorLuis G Pérez-Rivas, Marily Theodoropoulou, Troy H Puar, et al.
Neuro-Oncology|June 22, 2019
Driver mutations in USP8 wild-type Cushing's diseaseSilviu Sbiera, Luis Gustavo Perez-Rivas, Lyudmyla Taranets, et al.
The Lancet. Diabetes & Endocrinology|May 15, 2025
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trialAntoine Tabarin, Stéphanie Espiard, Timo Deutschbein, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2019
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German SurveyUlf Elbelt, Sven M Schlaffer, Michael Buchfelder, et al.
European Journal of Endocrinology|December 26, 2023
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgeryKristina Isand, Richard Feelders, Thierry Brue, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
Ebiomedicine|December 21, 2023
Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotypingLeah T Braun, Andrea Osswald, Stephanie Zopp, et al.
European Urology|November 26, 2013
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancerAlfredo Berruti, Martin Fassnacht, Harm Haak, et al.
European Journal of Endocrinology|October 7, 2017
Somatic <i>USP8</i> mutations are frequent events in corticotroph tumor progression causing Nelson's tumorLuis G Pérez-Rivas, Marily Theodoropoulou, Troy H Puar, et al.
Neuro-Oncology|June 22, 2019
Driver mutations in USP8 wild-type Cushing's diseaseSilviu Sbiera, Luis Gustavo Perez-Rivas, Lyudmyla Taranets, et al.
The Lancet. Diabetes & Endocrinology|May 15, 2025
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trialAntoine Tabarin, Stéphanie Espiard, Timo Deutschbein, et al.
Pageof 12